NCT02687932View on ClinicalTrials.gov

Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation

PHASE4CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 2, 2018

Study Completion Date

January 2, 2018

Conditions
Mitral Valve InsufficiencyLeft Ventricular Dysfunction
Interventions
DRUG

LCZ696

DRUG

Valsartan

Trial Locations (4)

Unknown

Inha University Hospital, Incheon

Samsung Medical Center, Seoul

Yonsei University Medical Center, Seoul

138-736

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Asan Medical Center

OTHER

NCT02687932 - Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation | Biotech Hunter | Biotech Hunter